Figure 2.

Eight-hour studies with glucagon-like peptide 1. Plasma glucose, pancreatic polypeptide(HPP), incremental glucagon, free immunoreactive insulin, and lactate responses to breakfast and lunch with subcutaneous injection of 0.63 μg/kg GLP-1 (closed circles) or vehicle (open circles) immediately before meals in volunteers with type 1 diabetes, n = 9.

Behme et al. BMC Endocrine Disorders 2003 3:3   doi:10.1186/1472-6823-3-3
Download authors' original image